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Abstract
Background: To assess synthetically the association between polymorphisms in the vitamin D receptor (VDR) gene (FokI, 
BsmI, ApaI, and TaqI) and diabetic retinopathy (DR).
Methods: Pubmed, Embase, ISI Web of  Science, Google-scholar and CBMDisc, CNKI and Chongqing VIP databases were 
searched. A meta-analysis was performed.
Results: Six studies with 636 cases and 1,035 controls were included in this meta-analysis. The outcomes showed that the FokI 
polymorphism (F allele) of  VDR gene had no statistical protective relationship with DR in overall studies. Interestingly, stratifi-
cation analysis showed that the FokI polymorphism (Fallele) was significantly associated with decreased DR risk in the Chinese 
population, among included studies without publication bias, during a comparison analysis between normal subjects and DR 
patients, and among articles published after 2010. However, the TaqI, BsmI and ApaI polymorphisms of  VDR gene had no 
significant association with the risk of  DR.
Conclusion: This meta-analysis of  case-control studies revealed that the VDR-FokI polymorphism (F allele) decreased the risk 
of  DR in Chinese people, among included studies without publication bias, during a comparison analysis between normal sub-
jects and DR patients, and among articles published after 2010. Further rigorous and prospective studies with large sample size 
are needed to confirm our findings.
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Introduction
To date, diabetic retinopathy (DR) is one of  most com-
mon causes of  visual impairment (VI) in adults starting 
from the age of  20 years until 74 years1. According to the 
reports by the World Health Organization (WHO), there 
were 4.8% of  the 37 million annual cases of  blindness by 
DR worldwide2. A pooled analysis, 1980-2008, revealed 
that the global prevalence of  DR was 34.6% (95% confi-
dence interval, CI: 34.5-34.8%) in patients with diabetes3. 
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Although many strategies are performed to prevent DR4, 
DR is more prevalent with the increasing prevalence of  
diabetes mellitus (DM), especially in China5. The mecha-
nisms of  DR are sophisticated and there are many stud-
ies to identify a number of  potential susceptibility genes 
for DR including those coding for vascular endothelial 
growth factor (VEGF)6, angiotensin converting enzyme 
(ACE)7, aldose reductase (ALR)8 and receptor for ad-
vanced glycation end products (RAGE)9.
Furthermore, many studies have shown that Vitamin D 
plays an important role in calcium metabolism, anti-an-
giogenic activities and inhibition of  proliferation10-12. The 
vitamin D receptor (VDR) is a ligand-dependent tran-
scription factor that in complex with hormonally active 
Vitamin D, and extensively express in vascular endothe-
lial cells of  humans retina13. The VDR gene is located 
on chromosome 12q13-12q14, and it has four frequently 
single nucleotide polymorphisms (SNPs). These are FokI 
G/A (rs2228570) change in exon 2, TaqI T/C (rs731236) 
change in exon 9, BsmI A/G (rs1544410), and ApaI G/T 
(rs7975232) changes in intron 8. Generally, the FokI poly-
morphism is located in the start codon, but the BsmI, 
ApaI and TaqI polymorphisms are located in the 3` UTR 
regions. Therefore, there is an alternative, a transcription 
initiation site, resulting in a VDR protein with three ad-
ditional amino acids. A Previous study revealed a nov-
el association between the functional VDR gene (FokI) 
polymorphism and a risk of  DR in patients with Type 
1 diabetes (T1DM)14. However, another study suggested 
that FokI polymorphism of  VDR gene did not increase 
risk of  DR in Type 2 diabetes (T2DM) in Poland15. Hence, 
previous studies concerning the association between the 
VDR-FokI gene polymorphism and the risk of  DR are 
limited and rather conflicting. In order to assess the pow-
erful-strength of  the association between the VDR gene 
polymorphism and susceptibility to DR, we conducted 
this meta-analysis, which would obtain a greater possibili-
ty of  acquiring or finding reasonably conclusions.
Methods
Search strategy
Two independent reviewers (WJY and LL) screened all 
studies on the relationship between VDR gene poly-
morphism and DR. Disagreements were dealt with by 
discussion. If  the results of  the discussion still had no 
agreement, another researcher (SY) would make the fi-
nal decision. Both English-language databases including 
Pubmed, Embase, ISI Web of  Science, Google (schol-
ar), and Chinese-language databases including China Na-
tional Knowledge Infrastructure (CNKI), Chinese Bio-
logical Medicine Disc (CBMDisc), Wan Fang (Chinese), 
Chongqing VIP database were searched using the terms 
"Vitamin D receptor or VD receptor or VDR", "diabetic 
retinopathy or DR" and "polymorphism, variant or mu-
tation". The last search was updated on June 10, 2017. 
Researchers checked reference lists manually to identify 
additional literatures. Searching was performed without 
any limits of  language, but only English or Chinese arti-
cles included.
Inclusion and exclusion criteria of  the study
Studies were included based on the following crite-
ria: (1) case-control studies; (2) complete information for 
VDR gene mutations with the risk of  DR for calculating 
the odds ratio (OR) with 95% CI directly and indirectly.
The exclusion criteria were as follows: (1) editorials, ab-
stracts, case reports, reviews and studies that used an ani-
mal or cell line, (2) any data that was insufficient or over-
lapping, (3) genotypes not in Hardy Weinberg equilibrium 
(HWE).
Data extraction and quality assessment
After selection process, data was extracted within a stan-
dard form by those two investigators. The following 
information was extracted: name of  the First author, 
location, publication year, ethnicity, sample sizes and 
genotype distributions of  cases and controls. Newcas-
tle-Ottawa Quality Assessment Scale (NOS)16 (Table 1) 
was used to evaluate the quality of  included studies. The 
score of  study with more than 6 stars was considered of  
relatively high quality.
This meta-analysis of  case-control studies was guided 
and performed by the PRISMA statement17 and MOOSE 
guidelines18.
Statistical analysis
The HWE was conducted for testing the distribution of  
genotypes in controls within each included study, and a 
P-value > 0.05 suggested that the study sample was rep-
resentative of  the population.
The ORs with 95% CI for allele and genotype models 
(homozygous model, heterozygous model, recessive 
model, and dominant model) were used to evaluate the 
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association between the VDR gene polymorphisms and 
the risk of  DR. I2 value was used to examine the Het-
erogeneity among eligible studies. When the heterogene-
ity was significant (I2 > 50%), the random-effects model 
(based on the DerSimonian and Laird method) would 
be used to evaluate the pooled ORs, if  not, pooled ORs 
could then be examined by the fixed-effects model (based 
on the Mantel-Haenszel method). The potential publica-
tion bias was assessed with a funnel plot and Egger re-
gression asymmetry test. An asymmetric plot suggested a 
possible publication bias and the P value of  Egger’s test 
less than 0.05 was considered representative of  statisti-
cally significant publication bias. If  there was publication 
bias, stratification analysis was carried in order to assess 
the reason for bias and strength the association between 
VDRgene polymorphisms and DR. All statistical tests 
were performed with Stata 11.0 software (StataCorp LP, 
College Station, TX, USA). All the P-values were two-sid-




After detailed screening the databases, six case-control 
articles (11 study-samples)14,15,19-22 with 636 cases of  any 
DR and 1,035 controls (including DM and normal sub-
jects) were included in this meta-analysis. There were five 
study-samples researched on the FokI polymorphisms 
including 535 cases and 936 controls, and two study-sam-
ples studied on the BsmI polymorphisms including 179 
cases and 408 controls, and two study-samples studied 
on the ApaI polymorphisms including 179 cases and 408 
controls, and two study-samples studied on the TaqI poly-
morphisms including 186 cases and 281 controls. The se-
lection process of  eligible studies was shown in Figure 
1. The qualities of  the included studies were evaluated 
by NOS; the quality scores of  six included studies were 
presented in Table 1. In addition, the characteristics of  
six articles were shown in Table 2. All of  including stud-
ies were consistent with HWE. All studies indicated that 
the controls were DM without DR or non-DM subjects 
except two articles by Taverna et al. involved non-severe 
DR subjects as controls14,22.
 
 
Figure 1. The flow chart of publication selection. 
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Taverna[14] ★ ☆ ☆ ★ ★★ ★ ★ ☆ 6 
Cyganek[15
] 
★ ★ ★ ★ ★★ ★ ★ ☆ 8 
Wu[19] ★ ★ ☆ ★ ★☆ ★ ★ ☆ 6 
Hou[20] ★ ★ ☆ ★ ★☆ ★ ★ ☆ 6 
Zhong[21] ★ ★ ☆ ★ ★☆ ★ ★ ☆ 6 
Taverna[22] ★ ★ ☆ ★ ★☆ ★ ★ ☆ 6 
 
Table  
Table 2. Characteristics of studies on DR and VDR polymorphism. 
Author Year Ethnicity Genotyping Methods Control Types 
Type of  
diabetes n (control) DR grade n (case) 
Duration of DM 
(case/control, year) Case Control HWE 
FokI      Male Female  Male Female  FF Ff ff F f FF Ff ff F f  
Wu[19] 2010 Chinese PCR-RFLP normal T2DM 32 30 Any DR 30 38 N/A 6 37 19 49 75 21 35 12 77 59 0.69 
Hou[20] 2015 Chinese PCR-RFLP normal T2DM 58 62 NPDR 40 40 N/A 5 20 55 30 130 14 50 56 78 162 0.58 
    DM  45 47 PDR 40 42  5 20 57 30 134 12 34 46 58 126 0.16 
Zhong[21] 2015 Chinese PCR–RFLP DM T2DM 51 59 Any DR 44 50 10.0/5.0 11 53 30 75 113 35 61 14 131 89 0.11 
    normal  54 62     N/A N/A N/A N/A N/A 40 58 18 138 94 0.68 
Cyganek[15] 2006 Caucasians  PCR–RFLP DM T2DM 85 97 Any DR 36 49 14.6/9.7 21 43 21 85 85 51 93 38 195 169 0.7 
Taverna[14] 2005 Caucasians PCR–RFLP Non-severe DR group T1DM 127 127 severe DR 59 67 25.5/25.1 38 65 23 111 141 15 56 57 86 170 0.82 
TaqI            TT Tt tt T t TT Tt tt T t  




T1DM 58 41 severe DR 45 56 30.0/25.2 27 58 16 112 90 42 44 13 128 70 0.78 
Cyganek[15] 2006 Caucasians  PCR–RFLP DM T2DM 85 97 Any DR 36 49 14.6/9.7 40 38 7 118 52 82 82 18 246 118 0.7 
BsmI            GG GA AA G A GG GA AA G A  
Zhong[21] 2015 Chinese PCR–RFLP DM T2DM 51 59 Any DR 44 50 10.0/5.0 5 27 62 37 151 6 27 77 39 181 0.09 
    normal  54 62  N/A N/A  N/A N/A N/A N/A N/A 2 18 96 22 210 0.3 
Cyganek[15] 2006 Caucasians  PCR–RFLP DM T2DM 85 97 Any DR 36 49 14.6/9.7 10 37 38 57 113 21 84 77 126 238 0.79 
ApaI            AA AC CC A C AA AC CC A C  
Zhong[21] 2015 Chinese PCR–RFLP DM T2DM 51 59 Any DR 44 50 10.0/5.0 27 54 13 108 80 34 60 16 128 92 0.2 
    normal  54 62  N/A N/A  N/A N/A N/A N/A N/A 29 59 28 117 115 0.85 
Cyganek[15] 2006 Caucasians  PCR–RFLP DM T2DM 85 97 Any DR 36 49 14.6/9.7 17 39 29 73 97 39 100 43 178 186 0.17 
 
Abbreviation: T2DM, type 2 diabetes mellitus; T1DM, type 1 diabetes mellitus; DR, diabetic retinopathy; N/A: Not Available. PCR-RFLP: Polymerase chain reaction-restriction fragment length polymorphism; HWE: Hardy Weinberg equilibrium; NPDR: non-proliferative diabetic retinopathy; PDR: proliferative diabetic 
retinopathy. 
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Meta-analysis
Overall, there was no link between VDR-FokI polymor-
phism and DR [F vs. f: OR = 0.68 (95% CI: 0.42-1.11); 
FF vs. ff: OR = 0.55 (95% CI: 0.14-2.11); Ff  vs. ff: OR = 
0.79, (95% CI: 0.39-1.62); FF vs. Ff+ff: OR = 0.62 (95% 
CI: 0.24-1.59); FF+Ff  vs. ff: OR = 0.73 (95% CI: 0.31-
1.72)]. In stratification analysis, the F allele in FokIpoly-
morphism lowered the risk of  DR in Chinese people [F 
vs. f: OR = 0.47 (95%CI: 0.38-0.58); FF vs. Ff: OR = 
0.23 (95%CI: 0.14-0.38); Ff  vs. ff: OR = 0.48 (95%CI: 
0.34-0.67); FF vs. Ff+ff: OR = 0.52 (95%CI: 0.33-0.83); 
FF+Ff  vs. ff: OR = 0.41 (95%CI: 0.29-0.56)], comparison 
between DR patients and non-DM subjects as controls [F 
vs. f: OR = 0.47 (95%CI: 0.37-0.59); FF vs. Ff: OR = 
0.23 (95%CI: 0.13-0.39); Ff  vs. ff: OR = 0.48 (95%CI: 
0.33-0.71); FF vs. Ff+ff: OR = 0.31 (95%CI: 0.19-0.5); 
FF+Ff  vs. ff: OR = 0.41 (95%CI: 0.28-0.58)], and stud-
ies published after 2010 [F vs. f: OR = 0.47 (95%CI: 
0.38-0.58); FF vs. Ff: OR = 0.23 (95%CI: 0.14-0.38); 
Ff  vs. ff: OR = 0.48 (95%CI: 0.34-0.67); FF vs. Ff+ff: 
OR = 0.52 (95%CI: 0.33-0.83); FF+Ff  vs. ff: OR = 0.41 
(95%CI: 0.29-0.56)], respectively. Moreover, the F allele 
in FokIpolymorphisms of  VDR gene had a protective 
effect on the risk of  DR when the study taken non-se-
vere DR subjects as controls was excluded [F vs. f: OR = 
0.56 (95%CI: 0.41-0.76); FF vs. Ff: OR = 0.31 (95%CI: 
0.15-0.64); Ff  vs. ff: OR = 0.54 (95%CI: 0.4-0.72); FF vs. 
Ff+ff: OR = 0.42 (95%CI: 0.23-0.77); FF+Ff  vs. ff: OR 
= 0.47 (95%CI: 0.35-0.62), Table 3.
Table 3. Pooled ORs and 95% CIs of overall and stratification analysis for association  
between DR and FokI polymorphism. 
 
FokI Study (n) Case Control F/f 
Effects-model 
(heterogeneity) P FF/ff 
Effects-model 
(heterogeneity) P Ff/ff 
Effects-model 
(heterogeneity) P FF/Ff+ff 
Effects-model 
(heterogeneity) P FF+Ff/ff 
Effects-model 
(heterogeneity) P 




















R (90.9%) 0.47 
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R (91.9%) 0.47 
Abbreviation: R, random effects-model; F, fixed-effects-model; OR, odds ratio; CI, confidence interval; T2DM, type 2 diabetes mellitus; DR, diabetic retinopathy. 
The results in Table 4, Table 5 and Table 6 indicated that 
there was no statistical significant association between 
polymorphisms in the VDR gene including BsmI, TaqI, 
ApaI and the risk of  DR.
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Table 4. Pooled ORs and 95% CIs of analysis for association between DR and ApaI polymorphism. 
Gene study case control A/C Effects-model(heterogeneity) P AA/CC Effects-model(heterogeneity) P AC/CC Effects-model(heterogeneity) P AA/AC+CC Effects-model(heterogeneity) P AA+AC/CC Effects-model(heterogeneity) P 












R (77%) 0.88 0.98 (0.66-1.49) F(0) 0.96 
0.93 (0.38-
2.31) R (76.6%) 0.88 
Abbreviation: R, random effects-model; F, fixed-effects-model; OR, odds ratio; CI, confidence interval; DR, diabetic retinopathy. 
 
Table 5. Pooled ORs and 95% CIs of analysis for association between DR and BsmI polymorphism. 
Gene study case control G/A Effects-model (heterogeneity) P GG/AA Effects-model (heterogeneity) P GA/AA Effects-model (heterogeneity) P GG/GA+AA Effects-model (heterogeneity) P GG+GA/AA Effects-model (heterogeneity) P 












R (59.7%) 0.53 0.8 (0.26-2.44) R (60.6%) 0.7 
1.23 (0.67-
2.26) R (62.9%) 0.49 
Abbreviation: R, random effects-model; F, fixed-effects-model; OR, odds ratio; CI, confidence interval; DR, diabetic retinopathy. 
 
Table 6. Pooled ORs and 95% CIs of analysis for association between DR and TaqI polymorphism. 
Gene study case control T/t Effects-model(heterogeneity) P TT/tt Effects-model(heterogeneity) P Tt/tt         Effects-model(heterogeneity) P TT/Tt+tt Effects-model(heterogeneity) P TT+Tt/tt Effects-model(heterogeneity) P 








R (43.2%) 0.59 1.12 (0.6-2.09) F(0) 0.19 
0.74 




F (0) 0.9 
Abbreviation: R, random effects-model; F, fixed-effects-model; OR, odds ratio; CI, confidence interval; DR, diabetic retinopathy. 
Publication bias
The potential publication bias was examined by using a 
funnel plot for the allele F vs. f  against the reciprocal of  
its standard error (Figure 2). Egger`s test provided con-
sistent results in the overall (t=−0.22, P<0.05); When the 
study in which control group including non-severe DR 
patients was excluded, there was no significant publica-
tion bias according to funnel plot (Figure 3).
 
 
Figure 2. The funnel plot with pseudo 95% confidence interval of all the  








Figure 3. The funnel plot with pseudo 95% confidence interval of the 
evaluable publications except for study which can effect on publication bias. 
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Figure 3. The funnel plot with pseudo 95% confidence interval of the 
evaluable publications except for study which can effect on publication bias. 
Discussion
We performed a meta-analysis of  case-control studies to 
evaluate the association between VDR gene polymor-
phisms and the risk of  DR. To the best of  our knowl-
edge, Vitamin D supplements will lower the risk of  DR in 
DM patients23. However, metabolic activation of  vitamin 
D is mediated through binding to a VDR. Therefore, the 
expression of  the VDR gene might be involved in the 
pathogenesis of  DR. There were some studies conducted 
on VDR gene polymorphisms that had been investigated 
and shown to be associated with presence of  any DR24,25. 
However, the published results were not consistent. Me-
ta-analysis is needed to strengthen the link between VDR 
gene polymorphisms and DR.
VDR gene is located in chromosomes 12q13-12q1426, 
and the allele of  FokI polymorphism is located in the 
5` end of  the VDR gene. Overall, there was no signifi-
cant association between VDR-FokI polymorphism and 
risk of  DR in this meta-analysis. Notably, we detected 
a significantly (F allele) decreased susceptibility for DR 
among Chinese population, cases with DR compared 
with normal controls, among studies without publication 
bias and articles published after 2010 year for all models. 
In contrast, there was no significant association that was 
found in Caucasians, cases with DR compared with DM 
controls, and even cases with DR compared with T2DM 
controls. Another meta-analysis revealed that FokI poly-
morphism was possibly a risk factor for T2DM, mostly 
in Chinese subjects27. However, it was inexplicable that F 
allele within FokI polymorphism lowered risk for DR in 
normal subjects rather than DM or T2DM.
BsmI, ApaI and TaqI are the other three polymorphisms 
for VDR gene. In our meta-analysis, there was no signifi-
cant association between these three polymorphisms and 
DR, which may be due to different locations of  VDR 
gene on its chromosome. These three polymorphisms are 
located in the 3` UTR regions of  VDR gene, but anoth-
er single-nucleotide polymorphism (FokI) located in the 
start codon of  VDR gene.
According to the results, there was significant heteroge-
neity detection in some genetic models. Although we have 
carried out stratification analysis, significant heterogene-
ity was also detected. After reviewing all included studies, 
different ethnicity and control subjects may contribute to 
the heterogeneity. Therefore, the conclusions should be 
interpreted with caution.
Another previous meta-analysis28 revealed that DR was 
significantly associated with VDR- FokI polymorphism 
both in overall and sub-group analysis which was not 
consistent with our results. Zhang et al. study has some 
limitations. There were seven studies included in that me-
ta-analysis but lacking of  the sub-groups analysis strati-
fied by control population (diabetic and normal subjects) 
or publication date. Moreover, there is lacking of  detailed 
description on study design in the research by Bućan K 
et al.25 which was also included in the Zhang`s meta-anal-
African Health Sciences Vol 18 Issue 4, December, 2018897
ysis. So we excluded this study and only six case-control 
studies were included in our current meta-analysis.
This meta-analysis has detected the association between 
VDR gene polymorphism and DR in stratification anal-
ysis. However, there were still several limitations in this 
study. First, relatively limited number of  case-control 
studies was included in meta-analysis. Thus, further stud-
ies involving large sample sizes are needed to archive more 
reliable conclusions on association between VDR gene 
polymorphisms and DR. Secondly, no analysis of  com-
bined genotype effects was done due to the small sample 
size. Third, the control groups within two eligible studies 
were including non-severe DR patients, which could lead 
to potential publication bias. Last but not least,, we did 
not include articles published in other languages only in 
English or Chinese. Although we have tried our best to 
review related articles in all databases, there were many 
unpublished, insufficient data studies missing.
Conclusion
This meta-analysis revealed a significant association be-
tween DR and VDR-FokI polymorphism in Chinese 
subjects, among included studies without publication 
bias, during a comparison analysis between normal sub-
jects and DR patients, and among articles published after 
2010. However, owing to the limitations of  this current 
meta-analysis, further prospective studies with larger 
sample sizes are needed to confirm our findings.
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